The early diagnostic value of ankle-brachial index combined with feet electrochemical skin conductance for peripheral artery disease in type 2 diabetes

J Diabetes Investig. 2022 Mar;13(3):525-531. doi: 10.1111/jdi.13687. Epub 2021 Oct 21.

Abstract

Aims/introduction: In this paper, we focused on exploring the diagnostic and predictive clinical utility of ankle-brachial index (ABI) in combination with feet electrochemical skin conductance (FESC) for peripheral artery disease (PAD) in Chinese patients with type 2 diabetes mellitus (T2DM).

Materials and methods: Overall, 183 Chinese T2DM patients were enrolled in this study. The patients were classified into three groups: Group 1 comprised of uncomplicated type 2 diabetics (n = 36), Group 2 consisted of patients with diabetic peripheral neuropathy (n = 103) whereas Group 3 patients displayed peripheral artery disease (n = 44). All patients underwent Sudoscan test using a Sudoscan (Paris, France) and ABI assessment.

Results: Multivariate logistic regression models revealed that FESC was an independent risk factor of developing PAD in patients with type 2 diabetes. The AUC for diagnostic, positive predictive and negative predictive value of ABI in combination with FESC for PAD were 0.907, 0.733 and 0.920, respectively. The specificity and sensitivity of ABI in combination with FESC for PAD were 0.914 and 0.750, respectively.

Conclusions: Ankle-brachial index in combination with FESC can accurately be used in early diagnosis of PAD.

Keywords: Ankle-brachial index; Electrochemical skin conductance; Peripheral artery disease.

MeSH terms

  • Ankle Brachial Index*
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / diagnosis
  • Diabetic Neuropathies* / complications
  • Galvanic Skin Response*
  • Humans
  • Peripheral Arterial Disease* / complications
  • Peripheral Arterial Disease* / diagnosis
  • Risk Factors